119 related articles for article (PubMed ID: 23423606)
1. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas.
Nordfors K; Haapasalo J; Sallinen PK; Haapasalo H; Soini Y
Histol Histopathol; 2013 Sep; 28(9):1137-46. PubMed ID: 23423606
[TBL] [Abstract][Full Text] [Related]
2. Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins.
Merikallio H; Kaarteenaho R; Pääkkö P; Lehtonen S; Hirvikoski P; Mäkitaro R; Harju T; Soini Y
J Clin Pathol; 2011 Feb; 64(2):136-40. PubMed ID: 21131312
[TBL] [Abstract][Full Text] [Related]
3. Twist predicts poor outcome of patients with astrocytic glioma.
Nordfors K; Haapasalo J; Mäkelä K; Granberg KJ; Nykter M; Korja M; Paavonen T; Haapasalo H; Soini Y
J Clin Pathol; 2015 Nov; 68(11):905-12. PubMed ID: 26163539
[TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical markers for prognosis of ependymal neoplasms.
Korshunov A; Golanov A; Timirgaz V
J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
[TBL] [Abstract][Full Text] [Related]
6. A survey of zeb1, twist and claudin 1 and 4 expression during placental development and disease.
Pirinen E; Soini Y
APMIS; 2014 Jun; 122(6):530-8. PubMed ID: 24304426
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
Korshunov A; Golanov A; Timirgaz V
J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
[TBL] [Abstract][Full Text] [Related]
8. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
9. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade.
Altura RA; Olshefski RS; Jiang Y; Boué DR
Br J Cancer; 2003 Nov; 89(9):1743-9. PubMed ID: 14583779
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.
Zawrocki A; Iżycka-Świeszewska E; Papierz W; Liberski PP; Zakrzewski K; Biernat W
Folia Neuropathol; 2011; 49(2):94-102. PubMed ID: 21845537
[TBL] [Abstract][Full Text] [Related]
11. Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas.
Nambirajan A; Sharma MC; Gupta RK; Suri V; Singh M; Sarkar C
Neuropathol Appl Neurobiol; 2014 Oct; 40(6):714-25. PubMed ID: 24224478
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
13. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
14. Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma.
Lemma S; Karihtala P; Haapasaari KM; Jantunen E; Soini Y; Bloigu R; Pasanen AK; Turpeenniemi-Hujanen T; Kuittinen O
Histopathology; 2013 Jan; 62(2):326-33. PubMed ID: 23190132
[TBL] [Abstract][Full Text] [Related]
15. Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.
Virág J; Haberler C; Baksa G; Piurkó V; Hegedüs Z; Reiniger L; Bálint K; Chocholous M; Kiss A; Lotz G; Glasz T; Schaff Z; Garami M; Hegedűs B
Pathol Oncol Res; 2017 Apr; 23(2):245-252. PubMed ID: 27395057
[TBL] [Abstract][Full Text] [Related]
16. Claudin expression in breast cancer: high or low, what to expect?
Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
Chen C; Chen L; Yao Y; Qin Z; Chen H
J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
19. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.
Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R
Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216
[TBL] [Abstract][Full Text] [Related]
20. [Study of claudins and prognostic factors in some gastrointestinal diseases].
Gyorffy H
Magy Onkol; 2009 Dec; 53(4):377-83. PubMed ID: 20071310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]